Overview and commentary of the CDEI's extended roadmap to an effective AI assurance ecosystem

In recent years, the field of ethical artificial intelligence (AI), or AI ethics, has gained traction and aims to develop guidelines and best practices for the responsible and ethical use of AI across sectors. As part of this, nations have proposed AI strategies, with the UK releasing both national AI and data strategies, as well as a transparency standard. Extending these efforts, the Centre for Data Ethics and Innovation (CDEI) has published an AI Assurance Roadmap, which is the first of its kind and provides guidance on how to manage the risks that come from the use of AI. In this article, we provide an overview of the document's vision for a “mature AI assurance ecosystem” and how the CDEI will work with other organizations for the development of regulation, industry standards, and the creation of AI assurance practitioners. We also provide a commentary of some key themes identified in the CDEI's roadmap in relation to (i) the complexities of building “justified trust”, (ii) the role of research in AI assurance, (iii) the current developments in the AI assurance industry, and (iv) convergence with international regulation

Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.

This study investigated the antispasticity potential of Sativex in mice. Chronic relapsing experimental allergic encephalomyelitis was induced in adult ABH mice resulting in hind limb spasticity development. Vehicle, Sativex, and baclofen (as a positive control) were injected intravenously and the "stiffness" of limbs assessed by the resistance force against hind limb flexion. Vehicle alone caused no significant change in spasticity. Baclofen (5 mg/kg) induced approximately a 40% peak reduction in spasticity. Sativex dose dependently reduced spasticity; 5 mg/kg THC + 5 mg/kg CBD induced approximately a 20% peak reduction; 10 mg/kg THC + 10 mg/kg CBD produced approximately a 40% peak reduction in spasticity. Sativex has the potential to reduce spasticity in an experimental mouse model of multiple sclerosis (MS). Baclofen reduced spasticity and served as a positive control. Sativex (10 mg/kg) was just as effective as baclofen, providing supportive evidence for Sativex use in the treatment of spasticity in MS

Expansion of a novel population of NK cells with low ribosome expression in juvenile dermatomyositis

Juvenile dermatomyositis (JDM) is a pediatric autoimmune disease associated with characteristic rash and proximal muscle weakness. To gain insight into differential lymphocyte gene expression in JDM, peripheral blood mononuclear cells from 4 new-onset JDM patients and 4 healthy controls were sorted into highly enriched lymphocyte populations for RNAseq analysis. NK cells from JDM patients had substantially greater differentially expressed genes (273) than T (57) and B (33) cells. Upregulated genes were associated with the innate immune response and cell cycle, while downregulated genes were associated with decreased ribosomal RNA. Suppressed ribosomal RNA in JDM NK cells was validated by measuring transcription and phosphorylation levels. We confirmed a population of low ribosome expressing NK cells in healthy adults and children. This population of low ribosome NK cells was substantially expanded in 6 treatment-naïve JDM patients and was associated with decreased NK cell degranulation. The enrichment of this NK low ribosome population was completely abrogated in JDM patients with quiescent disease. Together, these data suggest NK cells are highly activated in new-onset JDM patients with an increased population of low ribosome expressing NK cells, which correlates with decreased NK cell function and resolved with control of active disease

New evidence for the intentional use of calomel as a white pigment

In this work we report the results of the in-situ application of micro-Raman spectroscopy to the analysis of two historic painted objects: a 15th-century illuminated manuscript and a late-16th-century portrait miniature. Both objects were unexpectedly found to contain calomel (Hg2Cl2), intentionally used as a white pigment. Calomel was a widespread and popular medicine until it fell out of use at the end of the 19th century due to its toxicity, and a material called ‘mercury white’ is referred to in 16th-century technical literature on painting. However, although calomel has been recognised in the past as a degradation product of cinnabar in both wall and easel paintings, its deliberate use as a pigment on cultural heritage objects has only been documented recently, in white areas painted on 17th-century South American objects. The present study describes the first-ever verified use of calomel as a white pigment on European works of art, both of which pre-date its documented use in South America

Rayleigh superradiance and dynamic Bragg gratings in an end-pumped Bose-Einstein condensate

We study experimentally superradiant Rayleigh scattering from a Bose-Einstein condensate (BEC) in a new parameter regime where pump depletion and the exchange of photons between the endfire modes are important. Through experiments and simulations we show that collective atom light coupling leads to the self-organized formation of dynamic Bragg gratings within the sample. These gratings lead to an efficient back-scattering of pump photons and optical resonator structures within the BEC.Comment: 5 pages, 3 figure

Planning and delivery of intensity modulated bolus electron conformal therapy

PURPOSE: Bolus electron conformal therapy (BECT) is a clinically useful, well-documented, and available technology. The addition of intensity modulation (IM) to BECT reduces volumes of high dose and dose spread in the planning target volume (PTV). This paper demonstrates new techniques for a process that should be suitable for planning and delivering IM-BECT using passive radiotherapy intensity modulation for electrons (PRIME) devices. METHODS: The IM-BECT planning and delivery process is an addition to the BECT process that includes intensity modulator design, fabrication, and quality assurance. The intensity modulator (PRIME device) is a hexagonal matrix of small island blocks (tungsten pins of varying diameter) placed inside the patient beam-defining collimator (cutout). Its design process determines a desirable intensity-modulated electron beam during the planning process, then determines the island block configuration to deliver that intensity distribution (segmentation). The intensity modulator is fabricated and quality assurance performed at the factory (.decimal, LLC, Sanford, FL). Clinical quality assurance consists of measuring a fluence distribution in a plane perpendicular to the beam in a water or water-equivalent phantom. This IM-BECT process is described and demonstrated for two sites, postmastectomy chest wall and temple. Dose plans, intensity distributions, fabricated intensity modulators, and quality assurance results are presented. RESULTS: IM-BECT plans showed improved D CONCLUSION: These results demonstrated the feasibility of translating IM-BECT to the clinic using the techniques presented for treatment planning, intensity modulator design and fabrication, and quality assurance processes

Size-dependent spinodal and miscibility gaps for intercalation in nano-particles

Using a recently-proposed mathematical model for intercalation dynamics in phase-separating materials [Singh, Ceder, Bazant, Electrochimica Acta 53, 7599 (2008)], we show that the spinodal and miscibility gaps generally shrink as the host particle size decreases to the nano-scale. Our work is motivated by recent experiments on the high-rate Li-ion battery material LiFePO4; this serves as the basis for our examples, but our analysis and conclusions apply to any intercalation material. We describe two general mechanisms for the suppression of phase separation in nano-particles: (i) a classical bulk effect, predicted by the Cahn-Hilliard equation, in which the diffuse phase boundary becomes confined by the particle geometry; and (ii) a novel surface effect, predicted by chemical-potential-dependent reaction kinetics, in which insertion/extraction reactions stabilize composition gradients near surfaces in equilibrium with the local environment. Composition-dependent surface energy and (especially) elastic strain can contribute to these effects but are not required to predict decreased spinodal and miscibility gaps at the nano-scale

Laterally Orienting C. elegans Using Geometry at Microscale for High-Throughput Visual Screens in Neurodegeneration and Neuronal Development Studies

C. elegans is an excellent model system for studying neuroscience using genetics because of its relatively simple nervous system, sequenced genome, and the availability of a large number of transgenic and mutant strains. Recently, microfluidic devices have been used for high-throughput genetic screens, replacing traditional methods of manually handling C. elegans. However, the orientation of nematodes within microfluidic devices is random and often not conducive to inspection, hindering visual analysis and overall throughput. In addition, while previous studies have utilized methods to bias head and tail orientation, none of the existing techniques allow for orientation along the dorso-ventral body axis. Here, we present the design of a simple and robust method for passively orienting worms into lateral body positions in microfluidic devices to facilitate inspection of morphological features with specific dorso-ventral alignments. Using this technique, we can position animals into lateral orientations with up to 84% efficiency, compared to 21% using existing methods. We isolated six mutants with neuronal development or neurodegenerative defects, showing that our technology can be used for on-chip analysis and high-throughput visual screens